(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -10.15%33.53M | -11.39%34.75M | -11.97%154.94M | -16.41%35.71M | -10.92%42.69M | -13.48%37.32M | -7.14%39.22M | 6.96%176.01M | -2.55%42.73M | 19.17%47.92M |
Operating revenue | -10.15%33.53M | -11.39%34.75M | -11.97%154.94M | -16.41%35.71M | -10.92%42.69M | -13.48%37.32M | -7.14%39.22M | 6.96%176.01M | -2.55%42.73M | 19.17%47.92M |
Cost of revenue | -17.84%23.76M | -17.07%25.46M | -10.31%115.42M | -16.68%25.9M | -15.87%29.89M | -9.62%28.92M | 2.15%30.7M | 17.52%128.68M | 5.74%31.09M | 28.74%35.53M |
Gross profit | 16.28%9.77M | 9.09%9.29M | -16.50%39.52M | -15.68%9.81M | 3.29%12.79M | -24.55%8.4M | -30.06%8.52M | -14.04%47.33M | -19.42%11.64M | -1.78%12.39M |
Operating expense | -19.03%11.74M | -8.36%12.58M | -2.01%55.56M | -21.81%12.78M | 6.22%14.56M | 6.00%14.5M | 5.76%13.73M | 13.54%56.7M | 37.16%16.34M | 8.88%13.71M |
Selling and administrative expenses | -23.85%8.86M | -10.65%9.61M | -1.26%43.69M | -26.23%9.79M | 9.10%11.51M | 10.85%11.64M | 8.26%10.76M | 18.57%44.25M | 54.37%13.27M | 12.68%10.55M |
-General and administrative expense | -23.85%8.86M | -10.65%9.61M | -1.26%43.69M | -26.23%9.79M | 9.10%11.51M | 10.85%11.64M | 8.26%10.76M | 18.57%44.25M | 54.37%13.27M | 12.68%10.55M |
Depreciation amortization depletion | 0.60%2.87M | -0.07%2.97M | -4.67%11.87M | -2.73%2.99M | -3.39%3.05M | -10.02%2.86M | -2.40%2.97M | -1.35%12.46M | -7.38%3.08M | -2.14%3.16M |
-Depreciation and amortization | 0.60%2.87M | -0.07%2.97M | -4.67%11.87M | -2.73%2.99M | -3.39%3.05M | -10.02%2.86M | -2.40%2.97M | -1.35%12.46M | -7.38%3.08M | -2.14%3.16M |
Operating profit | 67.72%-1.97M | 36.85%-3.29M | -71.17%-16.04M | 36.96%-2.97M | -33.71%-1.77M | -140.02%-6.09M | -547.58%-5.21M | -283.01%-9.37M | -286.26%-4.71M | -7,063.16%-1.32M |
Net non-operating interest income (expenses) | -316.84%-1.58M | -390.85%-1.45M | -1,063.16%-19.93M | -3,660.88%-18.84M | -4.88%-408K | 7.77%-380K | 28.22%-295K | -53.36%-1.71M | -95.70%-501K | -64.83%-389K |
Non-operating interest income | -25.00%87K | -27.01%154K | 36.44%805K | 89.25%352K | -20.75%126K | -16.55%116K | --211K | 54.05%590K | --186K | --159K |
Non-operating interest expense | 236.90%1.67M | 216.60%1.6M | 800.13%20.73M | 2,693.89%19.19M | -2.55%534K | -9.98%496K | 23.11%506K | 53.53%2.3M | 7.51%687K | 132.20%548K |
Other net income (expenses) | 81.67%-600K | 92.65%-455K | 10.88%-21.4M | 64.30%-9.3M | -400.11%-2.64M | -1,162.66%-3.27M | -822.17%-6.19M | -247.18%-24.01M | -121.98%-26.05M | -34.62%878K |
Special income (charges) | 59.24%-1.08M | 77.76%-1.4M | -39.48%-22.67M | 36.38%-10.96M | -533.75%-2.78M | -1,685.14%-2.64M | -1,388.32%-6.29M | -4,103.20%-16.25M | -1,330.12%-17.23M | 2,470.37%640K |
-Less:Restructuring and mergern&acquisition | -69.29%754K | 427.21%1.61M | 772.94%6.36M | -52.05%819K | 533.75%2.78M | 1,558.78%2.46M | 162.50%305K | -59.58%728K | 41.74%1.71M | -2,470.37%-640K |
-Less:Impairment of capital assets | ---- | ---- | -11.57%9.22M | ---- | ---- | ---- | ---- | --10.43M | ---- | ---- |
-Less:Write off | ---- | ---- | -14.33%4.37M | ---- | ---- | ---- | ---- | --5.1M | ---- | ---- |
-Gain on sale of business | ---- | ---- | ---2.73M | --3.44M | --0 | ---- | ---- | --0 | --0 | --0 |
-Gain on sale of property,plant,equipment | -72.73%-323K | 103.51%210K | ---- | ---- | ---- | ---187K | ---5.98M | ---- | ---- | ---- |
Other non-operating income (expenses) | --519K | --621K | -83.30%680K | ---- | ---- | ---- | ---- | 319.46%4.07M | ---- | ---- |
Income before tax | 57.41%-4.15M | 55.59%-5.2M | -63.45%-57.37M | 0.48%-31.11M | -476.98%-4.81M | -268.79%-9.75M | -3,158.22%-11.7M | -1,105.22%-35.1M | -230.20%-31.26M | -174.07%-834K |
Income tax | 37.53%-1.2M | 75.62%-693K | 818.66%44.32M | 1,390.54%50.32M | -119.04%-1.23M | -69.37%-1.92M | -398.77%-2.84M | -64.10%-6.17M | -0.41%-3.9M | 52.81%-562K |
Earnings from equity interest net of tax | ||||||||||
Net income | 62.30%-2.95M | 49.15%-4.5M | -251.50%-101.69M | -197.61%-81.43M | -1,216.54%-3.58M | -419.11%-7.82M | -4,296.21%-8.85M | -3,519.50%-28.93M | -389.99%-27.36M | -111.74%-272K |
Net income continuous operations | 62.30%-2.95M | 49.15%-4.5M | -251.50%-101.69M | -197.61%-81.43M | -1,216.54%-3.58M | -419.11%-7.82M | -4,296.21%-8.85M | -3,519.50%-28.93M | -389.99%-27.36M | -111.74%-272K |
Noncontrolling interests | -8.82%331K | 97.99%-73K | -490.38%-2.44M | 113.31%214K | 31.09%624K | -58.70%363K | -514.71%-3.64M | -89.10%624K | -101.00%-1.61M | -78.77%476K |
Net income attributable to the company | 59.93%-3.28M | 15.10%-4.43M | -235.84%-99.25M | -217.02%-81.64M | -462.17%-4.21M | -243.08%-8.19M | -683.33%-5.22M | -505.59%-29.55M | -438.32%-25.75M | -1,097.33%-748K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 59.93%-3.28M | 15.10%-4.43M | -235.84%-99.25M | -217.02%-81.64M | -462.17%-4.21M | -243.08%-8.19M | -683.33%-5.22M | -505.59%-29.55M | -438.32%-25.75M | -1,097.33%-748K |
Diluted earnings per share | 50.00%-0.03 | 25.00%-0.03 | -245.45%-0.76 | -231.58%-0.63 | -200.00%-0.03 | -200.00%-0.06 | -300.00%-0.04 | -450.00%-0.22 | -383.92%-0.19 | -1,869.91%-0.01 |
Basic earnings per share | 50.00%-0.03 | 25.00%-0.03 | -245.45%-0.76 | -231.58%-0.63 | -200.00%-0.03 | -200.00%-0.06 | -300.00%-0.04 | -450.00%-0.22 | -383.92%-0.19 | -1,869.91%-0.01 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.